Tilde Rodrigues Froes

Tilde Rodrigues Froes

Auto-generated profile, based on publicly available information

Tilde Rodrigues Froes

Department of Veterinary Medicine, School of Veterinary Medicine, Federal University of Paraná, Curitiba, Brazil

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2014 in Theriogenology
Verified
Journal Article
Closed access
EGE.M.U. Gil
E.M.U. Gil
DGD.A.A. Garcia
D.A.A. Garcia
AGA.T. Giannico
A.T. Giannico
TFT.R. Froes
T.R. Froes

1 September 2015 in Theriogenology
Verified
Journal Article
Closed access
EGElaine M.U. Gil
Elaine M.U. Gil
DGDaniela A.A. Garcia
Daniela A.A. Garcia
TFTilde R. Froes
Tilde R. Froes

1 January 2009 in Genetics and Molecular Research
Verified
Journal Article
Closed access
CACarlos Eduardo Ambrosio
Carlos Eduardo Ambrosio
LFL. Fadel
L. Fadel
TGT.P. Gaiad
T.P. Gaiad
DMDaniele dos Santos Martins
Daniele dos Santos Martins
KAK.P.C. Araujo
K.P.C. Araujo
MMM.A. Miglino
M.A. Miglino
Duchenne muscular dystrophy (DMD) is a human disease characterized by progressive and irreversible skeletal muscle degeneration caused by mutations in genes coding for important muscle proteins. Unfortunately, there is no efficient treatment for this disease; it causes progressive loss of motor and muscular ability until death. The canine model (golden retriever muscular dystrophy) is similar to DMD, showing similar clinical signs. Fifteen dogs were followed from birth and closely observed for clinical signs. Dogs had their disease status confirmed by polymerase chain reaction analysis and genotyping. Clinical observations of musculoskeletal, morphological, gastrointestinal, respiratory, cardiovascular, and renal features allowed us to identify three distinguishable phenotypes in dystrophic dogs: mild (grade I), moderate (grade II) and severe (grade III). These three groups showed no difference in dystrophic alterations of muscle morphology and creatine kinase levels. This information will be useful for therapeutic trials, because DMD also shows significant, inter- and intra-familiar clinical variability. Additionally, being aware of phenotypic differences in this animal model is essential for correct interpretation and understanding of results obtained in pre-clinical trials.

1 April 2015 in Journal of Exotic Pet Medicine
Verified
Journal Article
Closed access
AGAmália Turner Giannico
Amália Turner Giannico
DGDaniela Aparecida Ayres Garcia
Daniela Aparecida Ayres Garcia
LLLeandro Lima
Leandro Lima
FLFátima Aparecida de Lara
Fátima Aparecida de Lara
CPClara Alita Corona Ponczek
Clara Alita Corona Ponczek
TFTilde Rodrigues Froes
Tilde Rodrigues Froes

1 July 2018 in Veterinary Anaesthesia and Analgesia
Verified
Journal Article
Closed access
FFFlávio Av. Freitag
Flávio Av. Freitag
VBViviane L. Bozak
Viviane L. Bozak
MCMichele Pw. Do Carmo
Michele Pw. Do Carmo
TFTilde R. Froes
Tilde R. Froes
JDJuan Cm. Duque
Juan Cm. Duque

1 March 2015 in Animal Reproduction Science
Verified
Journal Article
Closed access
AGAmália Turner Giannico
Amália Turner Giannico
EGElaine Mayumi Ueno Gil
Elaine Mayumi Ueno Gil
DGDaniela Aparecida Ayres Garcia
Daniela Aparecida Ayres Garcia
TFTilde Rodrigues Froes
Tilde Rodrigues Froes